covid Archives -

In the first of a three-part series, Ben Hargreaves looks at what the odds are of another pandemic

Preventing the next pandemic: Learning the lessons

https://pharmaphorum.com/r-d/preventing-the-next-pandemic-learning-the-lessons/

Deep Dive/ Sales and Marketing/ Views & Analysis/ Views and analysis

Refining digital collaboration

mike.hammerton@pharmaphorum.com Communications and Commercialisation, covid, Deep Dive, Deep Dive: Communications and Commercialisation, impetus, Natalie Yeadon 0 Comment

Pharmaceutical companies are traditionally more conservative with their approach to and incorporation of new technologies; however, prior to

Refining digital collaboration

https://pharmaphorum.com/sales-marketing/refining-digital-collaboration/

Crowd of adult citizens walking on city street - New reality lifestyle concept with senior people with covered faces - Selective focus on bearded man with blue protective mask

Oncology/ Views & Analysis/ Views and analysis

Blood Cancer UK: Hopes for our community’s future in the time of COVID

Kate Keightley blood cancer, Blood Cancer UK, covid, Gilead, Kite, patients 0 Comment

This thought leadership series has been paid and developed by Kite, a Gilead Company. This Blood Cancer Awareness

Blood Cancer UK: Hopes for our community’s future in the time of COVID

https://pharmaphorum.com/oncology/blood-cancer-uk-hopes-for-our-communitys-future-in-the-time-of-covid/

Deep Dive/ Oncology/ Views & Analysis/ Views and analysis

Cancer research faces uncertain post-COVID landscape

mike.hammerton@pharmaphorum.com cancer research, covid, Deep Dive, Deep Dive: Oncology, Oncology, Paul Workman, The Institute of Cancer Research 0 Comment

There’s a bright future ahead for cancer research in the UK, but only if the government is able

Cancer research faces uncertain post-COVID landscape

https://pharmaphorum.com/views-analysis-oncology/cancer-research-faces-uncertain-post-covid-landscape/

Deep Dive/ Oncology/ Views & Analysis/ Views and analysis

Oncology and a year of COVID: lessons for the future

mike.hammerton@pharmaphorum.com covid, Deep Dive, Deep Dive: Oncology, Frances O’Connor, Lucid, Lucid Group, Oncology, pandemic 0 Comment

COVID’s impact on cancer care and oncology research has been devastating, but the pandemic has also opened up

Oncology and a year of COVID: lessons for the future

https://pharmaphorum.com/views-analysis-oncology/oncology-and-a-year-of-covid-lessons-for-the-future/

Deep Dive/ Oncology/ Views & Analysis/ Views and analysis

How hybrid virtual engagement is accelerating oncology communication

mike.hammerton@pharmaphorum.com communication, covid, Deep Dive, Deep Dive: Oncology, Mike Abbadessa, Natalie DiMambro, Oncology, Sarah Diffen, Within3 0 Comment

COVID has revolutionised the way pharma engages with healthcare stakeholders – but to be truly successful, digital engagement

How hybrid virtual engagement is accelerating oncology communication

https://pharmaphorum.com/views-analysis-oncology/how-hybrid-virtual-engagement-is-accelerating-oncology-communication/

Deep Dive/ Oncology/ Views & Analysis/ Views and analysis

Why pharma shouldn’t forget about sites in a post-COVID world

mike.hammerton@pharmaphorum.com covid, Deep Dive, Deep Dive: Oncology, Oncology, syneos health 0 Comment

The pandemic forced massive changes to oncology sites to ensure patient safety and research continuity – but we

Why pharma shouldn’t forget about sites in a post-COVID world

https://pharmaphorum.com/views-analysis-oncology/why-pharma-shouldnt-forget-about-sites-in-a-post-covid-world/

Digital/ Views & Analysis/ Views and analysis

Keeping clinical trial data safe – handling cybersecurity in a risky world

Catherine Longworth clinical trials, covid, cyber attacks, cyber crime, cyber security 0 Comment

The development of vaccines for COVID-19 has been a masterclass in effective collaboration and applied digitisation in healthcare.

Keeping clinical trial data safe – handling cybersecurity in a risky world

https://pharmaphorum.com/views-and-analysis/keeping-clinical-trial-data-safe-handling-cybersecurity-in-a-risky-world/

Deep Dive/ R&D/ Views & Analysis/ Views and analysis

Inside the UK’s leading efforts to restart clinical research

mike.hammerton@pharmaphorum.com Clinical Research Network, covid, CRN, Deep Dive, National Institute for Health Research, NHS, NIHR, R&D, Research and Development 2021 0 Comment

A herculean national effort has seen 69% of paused studies due to COVID restarted under the National Institute

Inside the UK’s leading efforts to restart clinical research

https://pharmaphorum.com/r-d/views-analysis-r-d/inside-uks-leading-efforts-restart-clinical-research/

Trending

covid

Login